Register
Forgot your password?

Forty-three year survival with the ball-in-cage heart valveprosthesis (MKCH model 02) in the mitral positionof a female patient: hemodynamic result, health-relatedquality of life, medication therapy correction

Authors: Nikitina T.G., Pelekh D.M., Fadeev A.A., Glushko L.A., Il'yina V.E., Bockeria L.A.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

For correspondence:  Sign in or register.

Type:  Case reports


DOI: https://doi.org/10.24022/1997-3187-2019-13-3-274-284

For citation: Nikitina T.G., Pelekh D.M., Fadeev A.A., Glushko L.A., Il'yina V.E., Bockeria L.A. Forty-three year survival with the ball-in-cage heart valve prosthesis (MKCH model 02) in the mitral position of a female patient: hemodynamic result, health-related quality of life, medication therapy correction. Creative Cardiology. 2019; 13 (3): 274–84 (in Russ.). DOI: 10.24022/ 1997-3187-2019-13-3-274-284

Received / Accepted:  16.08.2019/01.09.2019

Keywords: mitral heart disease spherical mechanical prosthesis heart failure long-term result quality of life

Full text:  

 

Abstract

Female, 60 years old, underwent mitral valve replacement with a caged ball mechanical prosthesis MKCH-02 at the Bakoulev Center (BC) in 1976 at the age of 18. Over the next 37 years the patient kept on follow-up in the polyclinic department of BC. Prosthesis function and the degree of cardiac cavity remodeling were performed by Echo. Also medical treatment correction, including an anticoagulant therapy was performed. According to the move to another region of the country, the patient dropped out of the supervision for five years. In August 2018, the patient again was admitted to the BC with the heart failure signs. According to echocardiography, the function of the ball prosthesis is normal, cardiomegaly, atriomegaly and pulmonary hypertension were noted; on Holter monitoring ventricular rhythm disturbances were registered. The patient was treated for heart failure (HF), as well as correction of the anticoagulant therapy was made. On the 7th day, subcompensation was achieved: the HF functional class was NYHA – II, the volume of the heart chambers decreased as well as pressure in pulmonary artery according to Echo, decreased the frequency of ventricular arrhythmia by Holter. Testing on the quality of life questionnaires was performed (SF-36 and DASI): a satisfactory physical and mental condition, a good level of social functioning were noted.

References

  1. Burakovskiy V. I. Heart surgery in the USSR- mainachievements and some future prospects. ThoracicSurgery. 1977; 5: 14–22 (in Russ.).
  2. Balakirev E.M. Valeriy Ivanovich Shumakov andhis school. Russian Annals of Surgery. 2001; 5: 5–11(in Russ.).
  3. Gritsenko V.V., Orlovskiy P.I., Perimov Yu.A. et al.On the history of creation and introduction of thefirst small-sized artificial heart valves in Russia.Vestnik Khirurgii named after I.I. Grekov.2009; 3:94–7 (in Russ.).
  4. Tsuckerman G.I., Bykova V.A., Semenovsky M.L.,Golikov G.T. Full replacement of the mitral valve.Thoracic Surgery. 1968; 1: 12–8 (in Russ.).
  5. Tsuckerman G.I., Semenovsky M.L., Il'yina V.E.,Kosach G.A., Pomortseva L.V., Klimchuk Z.G.Late results and perspectives of cardiac valvesreplacement. Kardiologiia. 1974; XIV (8): 36–41(in Russ.).
  6. Bockeria L.A. Bakoulev Center report for researchand medical care works for 2008. The Bulletin ofBakoulev Center for Cardiovascular Diseases.2009;10 (1) (Suppl.): 73–5 (in Russ.).
  7. Gott V.L., Alejo D.E., Cameron D.E. Mechanical heart valves: 50 years of evolution. Ann. Thorac. Surg. 2003; 76: S2230–9.
  8. Starr A., Grunkemeier G.L. Beyond 24 years with the aortic Starr-Edwards silastic ball valve: a valve of the past? – No! Eur. J. Cardiovasc. Surg. 1993; 7: 113–6.
  9. Abad C., Hernandez-Ramirez L.M., Caballero E. Patient lives almost 50 years after aortic valve replacement with a Starr-Edwards caged-ball valve. Texas Heart Ins. J. 2016; 43 (6): 562.
  10. Starr A., Grunkemeier G.L. Durability of the Starr-Edwards heart valve: early decisions led to successful results. Tex. Heart Inst. J. 2016; 43 (1): 2–3.
  11. Tsukerman G.I., Travin A.A., Giorgadze O.A.,Arutyunyan N.V., Yaroshinskiy Y.N. On measurespreventing ligation of the circumflexing branch ofthe left coronary artery when replacing mitralvalve. Thoracic Surgery.1976; 4: 20–4 (in Russ.).
  12. Volkers E.J., Algra A., Kapelle L.J., Greving J.P. Prediction models for clinical outcome after a carotid revascularization procedure: A systematic review. Eur. Stroke J. 2018; 3 (1): 57–65.
  13. Emery R.W., Emery A.M., Knutsen A.I., Raikar G.V. Aortic valve replacement with a mechanical cardiac valve prosthesis. In: Cohn L. (Ed.) Cardiac surgery in the adult. New York: McGraw-Hill; 2008: 841–56.
  14. Yoganathan A.P., Travis B.R. Fluid dynamics of prosthetic valves. In: Otto C.M. (Ed.) The practice of clinical echocardiography. 2nd ed. Philadelphia: W.B. Saunders Company; 2002: 501–24.
  15. Zavalgoitia M. Echocardiographic recognition and quantitation of prosthetic valve dysfunction. In: Otto C.M. (Ed.) The practice of clinical echocardiography. 2nd ed. Philadelphia: W.B. Saunders Company; 2002: 525–50.
  16. Akins C.W. Results with mechanical cardiac valvular prostheses. Ann. Thorac. Surg. 1995; 60: 1836–44. DOI: 10.1016/0003-4975(95)00766-0
  17. Akins C.W. Results with mechanical cardiacvalvular prostheses. Ann. Thorac. Surg.1995; 60:1836–44. DOI: 10.1016/0003-4975(95)00766-0
  18. Fadeev A.A. Designs and functional properties ofheart valve prostheses. Russian Annals of Surgery.2013; 3: 9–18 (in Russ.).
  19. Bockeria L.A., Fadeev A.A., Makhachev O.A.,Mel'nikov A.P., Bondarenko I.E. Mechanical heartvalve prostheses. Moscow; 2013 (in Russ.).
  20. Li M., Dumesnil J.G., Mathieu P., Pibarot P. Impact of valve prosthesis-patientmismatch on pulmonary arterial pressure after mitral valve replacement. J. Am. Coll. Cardiol. 2005; 45: 1034–40.
  21. Pelekh D.M., Nikitina T.G., Fadeev A.A., Skopin I.I.,Izosimova M.G. Clinical status assessment ofa female patient with double the normal body massindexand with a severevalve prosthesis/patient mis-match 15 years after the mitral and aortic valvesreplacement with St. Jude Medical Standardmechanical prostheses. Clinical Physiology ofCirculaiton.2017; 14 (3): 170–7. DOI: 10.24022/1814-6910-201714-3-170-177
  22. Gödje O.L., Fischlein T., Adelhard K., Nollert G., Klinner W., Reichart B. Thirty-year results of starredwards prostheses in the aortic and mitral position. Ann. Thorac. Surg. 1997; 63: 613–9.
  23. Gao G., Wu Y., Grunkemeier G.L., Furnary A.P., Starr A. Forty year survival with the Starr-Edwards heart valve prosthesis. J. Heart Valve Dis. 2004; 13: 91–6.
  24. Battaglia F., Mielniczuk L., Dupuis J., Chan V. Explant of a ball and cage valve 42 years after initial implant. J. Thorac. Cardiovasc. Surg. 2018; 155: e147–8.
  25. Nikitina T.G., Geletsyan L.G., Izosimova M.G.,Mal'tsev D.P. The outcome of surgical correctionof mitral-aortic defect with the use of ball-in-cageprostheses without preservation of the subvalvularmitral apparatus in a female patient underwentsurgery in 1971. Russian Journal of Thoracic andCardiovascular Surgery. 2013; 2: 27–9 (in Russ.).
  26. Nikitina T.G., Guliang K.S., Nezhdanov I.B.,Plusch M.G., Samsonova N. N., Skopin I.I. Valueof brain natriuretic peptide in the diagnostics ofdevelopment of complications after surgical cor-rection of heart valve diseases and a revasculariza-tion of a myocardium. Clinical Physiology ofCirculaiton. 2011; 55 (2): 27–9 (in Russ.).
  27. Bockeria O.L., Geletsyan L.G., Averina I.I., Po-pov D.A., Glushko L.A., Sokol'skaya M.A. Keyaspects of preoperative assessment and planning ofpatients for cardiovascular interventions. TheBulletin of Bakoulev Center for CardiovascularDiseases.2018; 19 (3): 327–37 (in Russ.).

About Authors

  • Tatyana G. Nikitina, Dr. Med. Sc., Professor, Head of Department, ORCID;
  • Dmitriy M. Pelekh, Cand. Med. Sc., Researcher, Cardiologist, ORCID;
  • Aleksander A. Fadeev, Cand. Tech. Sc., Head of Laboratory, ORCID;
  • Lyudmila A. Glushko, Cand. Med. Sc., Head of Pulmonary Samples and Gas Exchange Monitoring Group, Cardiologist, ORCID;
  • Valentina E. Il'yina, Dr, Med. Sc., Senior Researcher, Cardiovascular Surgeon;
  • Leo A. Bockeria, Academician of Russian Academy of Sciences and Russian Academy of Medical Sciences, Director, ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by